Table of Contents What happens next: DOJ and DEA pathways Once rescheduling occurs, then what? A potential bright spot: marijuana exports and the global market Will this effect the recently closed hemp loophole? Timing and what to expect going forward How Democrats...
By Shawn Hauser, Daniel Molina, Andrew Livingston, Will Woodlee, Helen Ryan Dec 16, 2025 In this collaborative analysis, Vicente LLP and the preeminent FDA law firm Kleinfeld, Kaplan & Becker LLP examine how the potential reclassification of cannabis into Schedule...
On Monday, the U.S. Supreme Court denied certiorari in Canna Provisions, Inc. et al. v. Bondi, a high-profile lawsuit that challenged the constitutionality of the federal prohibition of intrastate (and not interstate) cannabis activity. The denial offered no...
Precision Breeding in England: Navigating the New Regulatory Framework 9 December 2025 Authored and Edited by Hannah Whitmore, Ph.D.; K. Victoria Barker, Ph.D.; Victoria A. Randall, Ph.D. On 13 November 2025, England introduced the Genetic Technology (Precision...
In our previous legal update last month, we outlined language included in one of the appropriations bills which was passed in connection with ending the historic government shutdown. The package contained language that, among other things, recriminalized synthetic or...
How Will the Cannabis World Look When Marijuana Is Rescheduled? A few weeks ago, someone at a holiday party asked “Whitt, why doesn’t Budding Trends take on the weighty legal issues of the day and instead resort to cheap pop culture references and puns?” I thought...